Free Trial

Generation Bio (GBIO) Insider Trading & Ownership

Generation Bio logo
$0.95 +0.00 (+0.18%)
As of 01/17/2025 04:00 PM Eastern

Generation Bio (NASDAQ:GBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$203,209.36
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$18,410.06
Get GBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Generation Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GBIO Insider Buying and Selling by Quarter

Generation Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/13/2025Anthony G QuinnDirectorBuy85,000$0.97$82,450.00  
1/10/2025Anthony G QuinnDirectorBuy125,791$0.96$120,759.36  
7/1/2024Antoinette PaoneCOOSell6,719$2.74$18,410.06  
(Data available from 1/1/2013 forward)

GBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Generation Bio includes Anthony G Quinn, Antoinette Paone, Charles A Rowland Jr, Dannielle Appelhans, Donald William Nicholson, and Phillip Samayoa. Learn more on insiders at GBIO.

21.10% of Generation Bio stock is owned by insiders. Learn more on GBIO's insider holdings.

The following insiders have purchased GBIO shares in the last 24 months: Anthony G Quinn ($203,209.36), and Dannielle Appelhans ($19,159.34).

Insiders have purchased a total of 223,428 GBIO shares in the last 24 months for a total of $222,368.70 bought.

The following insiders have sold GBIO shares in the last 24 months: Antoinette Paone ($66,150.58), and Phillip Samayoa ($16,483.64).

Insiders have sold a total of 21,005 Generation Bio shares in the last 24 months for a total of $82,634.22 sold.

Generation Bio Key Executives

  • Dr. Cameron Geoffrey McDonough M.D. (Age 54)
    President, CEO & Director
    Compensation: $939.09k
  • Dr. Matthew Norkunas M.B.A. (Age 45)
    M.D., Chief Financial Officer
    Compensation: $611.11k
  • Dr. Matthew Stanton Ph.D. (Age 50)
    Chief Scientific Officer
    Compensation: $654.83k
  • Dr. Mark D. Angelino Ph.D. (Age 51)
    Co-Founder
  • Dr. Robert Kotin Ph.D. (Age 68)
    Co-Founder
  • Ms. Antoinette Paone M.B.A. (Age 45)
    M.S., Chief Operating Officer
  • Ms. Yalonda Howze J.D. (Age 51)
    Chief Legal Officer & Secretary
  • Ms. Jasmin Tower
    Chief Human Resources Officer
  • Dr. Phillip Samayoa Ph.D. (Age 36)
    Chief Strategy Officer


This page (NASDAQ:GBIO) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners